Moslein G | Seppälä Labhttps://www.seppalalab.org/author/moslein-g/Moslein GHugo Blox Builder (https://hugoblox.com)enWed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pngMoslein Ghttps://www.seppalalab.org/author/moslein-g/Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequenceshttps://www.seppalalab.org/publication/moller-2025-colorectal/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/moller-2025-colorectal/Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revisionhttps://www.seppalalab.org/publication/zaffaroni-2024-updated/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/zaffaroni-2024-updated/Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelineshttps://www.seppalalab.org/publication/cavestro-2023-delphi/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/cavestro-2023-delphi/Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statementhttps://www.seppalalab.org/publication/moller-2023-dominantly/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/moller-2023-dominantly/Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databasehttps://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-uphttps://www.seppalalab.org/publication/mathers-2022-cancer/Sat, 01 Jan 2022 00:00:00 +0000https://www.seppalalab.org/publication/mathers-2022-cancer/The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patientshttps://www.seppalalab.org/publication/bohaumilitzky-2022-the/Sat, 01 Jan 2022 00:00:00 +0000https://www.seppalalab.org/publication/bohaumilitzky-2022-the/European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and genderhttps://www.seppalalab.org/publication/seppala-2021-european/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2021-european/No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Studyhttps://www.seppalalab.org/publication/dominguez-valentin-2021-no/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2021-no/Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database reporthttps://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillancehttps://www.seppalalab.org/publication/ahadova-2021-the/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/ahadova-2021-the/Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database reporthttps://www.seppalalab.org/publication/seppala-2021-uptake/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2021-uptake/Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndromehttps://www.seppalalab.org/publication/engel-2020-associations/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/engel-2020-associations/Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Databasehttps://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Databasehttps://www.seppalalab.org/publication/dominguez-valentin-2020-correction/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2020-correction/Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/seppala-2019-lack/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2019-lack/Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/dominguez-valentin-2019-survival/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2019-survival/